These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2140971)

  • 1. [Center monitoring and management of data bases].
    Roncolato M; Meneghetti M
    Clin Ter; 1990 Mar; 132(6 Suppl):469-73. PubMed ID: 2140971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodology of a clinical controlled study of L-acetylcarnitine].
    Neri M; Cortelloni C; De Vreese L
    Clin Ter; 1990 Mar; 132(6 Suppl):457-68. PubMed ID: 2140970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methodological premises of statistical analysis of the data].
    Bamfi F; Girelli M
    Clin Ter; 1990 Mar; 132(6 Suppl):475-8. PubMed ID: 2140972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aging of the population: the 2d demographic revolution].
    Recchia G
    Clin Ter; 1990 Mar; 132(6 Suppl):443-50. PubMed ID: 2140968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild-to-moderate mental deterioration in the aged. Conclusions].
    Genazzani E
    Clin Ter; 1990 Mar; 132(6 Suppl):511-2. PubMed ID: 2140974
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
    Cipolli C; Chiari G
    Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical development of a drug for brain aging. Current limitations and future prospects].
    Zerbini O; Recchia G; Fabbri L
    Clin Ter; 1990 Mar; 132(6 Suppl):451-5. PubMed ID: 2140969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
    Acierno G
    Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
    Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G
    Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary study on the use of acetylcarnitine in patients with mental deterioration].
    Testa G; Giaretta D; Pellegrini A; Chemello R; Freddo L; Angelini C
    Riv Neurol; 1982; 52(3):185-97. PubMed ID: 7134758
    [No Abstract]   [Full Text] [Related]  

  • 12. L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
    Goety CG; Tanner CM; Cohen JA; Thelen JA; Carroll VS; Klawans HL; Fariello RG
    Mov Disord; 1990; 5(3):263-5. PubMed ID: 2143808
    [No Abstract]   [Full Text] [Related]  

  • 13. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo.
    Tempesta E; Casella L; Pirrongelli C; Janiri L; Calvani M; Ancona L
    Drugs Exp Clin Res; 1987; 13(7):417-23. PubMed ID: 3308388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological brain ageing: evaluation of the efficacy of a pharmacological aid.
    Guarnaschelli C; Fugazza G; Pistarini C
    Drugs Exp Clin Res; 1988; 14(11):715-8. PubMed ID: 3246216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
    Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
    Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R
    Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
    Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical investigations: innovative management of data. Electronic Data Capture: IOStudy Office].
    Marschner N
    Zentralbl Gynakol; 2001 Aug; 123(8):441-3. PubMed ID: 11562806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZ-Entry: a clinical data management system.
    Gao QB; Kong Y; Fu Z; Lu J; Wu C; Jin ZC; He J
    Comput Biol Med; 2008 Sep; 38(9):1042-4. PubMed ID: 18760776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodology of a controlled clinical study for cerebral aging evaluation.
    Vecchi GP; Neri M; Cortelloni C; De Vreese L; Sirotti C; Cipolli C; Fabbri L; Zerbini O
    Int J Clin Pharmacol Res; 1990; 10(1-2):145-52. PubMed ID: 2201654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.